|
|
 |
|
Total Number of Holdings (excluding cash): 73
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Pharmaceuticals and Biotechnology |
37,598 |
$24,483,065.64 |
2.47% |
| DaVita Inc. |
DVA |
23918K108 |
Health Care Providers |
105,371 |
$24,454,501.68 |
2.46% |
| The Cigna Group |
CI |
125523100 |
Health Care Providers |
85,039 |
$24,223,359.15 |
2.44% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals and Biotechnology |
973,556 |
$24,163,659.92 |
2.43% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
Medical Equipment and Services |
272,312 |
$24,148,628.16 |
2.43% |
| Centene Corporation |
CNC |
15135B101 |
Health Care Providers |
365,217 |
$24,064,148.13 |
2.42% |
| Boston Scientific Corporation |
BSX |
101137107 |
Medical Equipment and Services |
549,279 |
$23,602,518.63 |
2.38% |
| Solventum Corporation |
SOLV |
83444M101 |
Medical Equipment and Services |
303,865 |
$23,592,078.60 |
2.38% |
| Guardant Health, Inc. |
GH |
40131M109 |
Pharmaceuticals and Biotechnology |
156,258 |
$23,555,893.50 |
2.37% |
| Universal Health Services, Inc. (Class B) |
UHS |
913903100 |
Health Care Providers |
157,664 |
$23,545,541.76 |
2.37% |
| Axsome Therapeutics, Inc. |
AXSM |
05464T104 |
Pharmaceuticals and Biotechnology |
95,778 |
$22,950,324.36 |
2.31% |
| Natera, Inc. |
NTRA |
632307104 |
Medical Equipment and Services |
86,364 |
$22,819,096.08 |
2.30% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
Medical Equipment and Services |
296,711 |
$22,401,680.50 |
2.26% |
| Medline Inc. (Class A) |
MDLN |
58507V107 |
Medical Equipment and Services |
594,403 |
$22,099,903.54 |
2.23% |
| Encompass Health Corporation |
EHC |
29261A100 |
Health Care Providers |
173,171 |
$19,225,444.42 |
1.94% |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Pharmaceuticals and Biotechnology |
214,749 |
$19,048,236.30 |
1.92% |
| Medtronic Plc |
MDT |
G5960L103 |
Medical Equipment and Services |
223,755 |
$18,323,296.95 |
1.85% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals and Biotechnology |
201,314 |
$18,295,416.32 |
1.84% |
| Tenet Healthcare Corporation |
THC |
88033G407 |
Health Care Providers |
93,566 |
$18,278,118.10 |
1.84% |
| QIAGEN N.V. |
QGEN |
N72482156 |
Pharmaceuticals and Biotechnology |
447,678 |
$18,162,296.47 |
1.83% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals and Biotechnology |
243,587 |
$18,071,719.53 |
1.82% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Pharmaceuticals and Biotechnology |
103,861 |
$17,935,756.09 |
1.81% |
| Incyte Corporation |
INCY |
45337C102 |
Pharmaceuticals and Biotechnology |
154,412 |
$17,879,365.48 |
1.80% |
| Elevance Health Inc. |
ELV |
036752103 |
Health Care Providers |
45,263 |
$17,611,380.67 |
1.77% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Pharmaceuticals and Biotechnology |
223,640 |
$17,403,664.80 |
1.75% |
| ResMed Inc. |
RMD |
761152107 |
Medical Equipment and Services |
89,821 |
$17,327,369.11 |
1.75% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals and Biotechnology |
32,305 |
$17,026,996.35 |
1.72% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals and Biotechnology |
14,595 |
$16,974,130.95 |
1.71% |
| Ascendis Pharma A/S |
ASND |
K08588103 |
Pharmaceuticals and Biotechnology |
65,629 |
$16,533,913.97 |
1.67% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals and Biotechnology |
885,763 |
$15,066,828.63 |
1.52% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals and Biotechnology |
244,116 |
$14,832,488.16 |
1.49% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals and Biotechnology |
111,334 |
$14,511,273.56 |
1.46% |
| Becton, Dickinson and Company |
BDX |
075887109 |
Medical Equipment and Services |
92,948 |
$14,235,915.68 |
1.43% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Pharmaceuticals and Biotechnology |
258,517 |
$14,213,264.66 |
1.43% |
| Labcorp Holdings Inc. |
LH |
504922105 |
Medical Equipment and Services |
50,235 |
$14,139,143.10 |
1.42% |
| Steris Plc |
STE |
G8473T100 |
Medical Equipment and Services |
66,800 |
$14,066,076.00 |
1.42% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Pharmaceuticals and Biotechnology |
26,560 |
$14,026,867.20 |
1.41% |
| Doximity, Inc. (Class A) |
DOCS |
26622P107 |
Health Care Providers |
678,204 |
$13,896,399.96 |
1.40% |
| Quest Diagnostics Incorporated |
DGX |
74834L100 |
Medical Equipment and Services |
66,364 |
$13,925,158.12 |
1.40% |
| Revolution Medicines, Inc. |
RVMD |
76155X100 |
Pharmaceuticals and Biotechnology |
75,107 |
$13,746,834.21 |
1.39% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
Medical Equipment and Services |
219,746 |
$13,494,601.86 |
1.36% |
| Biogen Inc. |
BIIB |
09062X103 |
Pharmaceuticals and Biotechnology |
65,101 |
$12,873,071.74 |
1.30% |
| Abbott Laboratories |
ABT |
002824100 |
Medical Equipment and Services |
96,454 |
$9,700,378.78 |
0.98% |
| BridgeBio Pharma, Inc. |
BBIO |
10806X102 |
Pharmaceuticals and Biotechnology |
117,510 |
$9,713,376.60 |
0.98% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals and Biotechnology |
177,398 |
$9,581,265.98 |
0.97% |
| Chemed Corporation |
CHE |
16359R103 |
Health Care Providers |
18,791 |
$9,461,644.32 |
0.95% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
Medical Equipment and Services |
17,457 |
$9,190,412.22 |
0.93% |
| Veeva Systems Inc. (Class A) |
VEEV |
922475108 |
Health Care Providers |
49,317 |
$9,101,452.35 |
0.92% |
| IQVIA Holdings Inc. |
IQV |
46266C105 |
Health Care Providers |
45,297 |
$8,992,360.44 |
0.91% |
| Align Technology, Inc. |
ALGN |
016255101 |
Medical Equipment and Services |
51,891 |
$8,949,121.86 |
0.90% |
| Henry Schein, Inc. |
HSIC |
806407102 |
Medical Equipment and Services |
104,791 |
$8,887,324.71 |
0.90% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals and Biotechnology |
34,779 |
$8,809,520.70 |
0.89% |
| Agilent Technologies, Inc. |
A |
00846U101 |
Medical Equipment and Services |
65,889 |
$8,793,545.94 |
0.89% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Pharmaceuticals and Biotechnology |
16,300 |
$8,763,695.00 |
0.88% |
| Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals and Biotechnology |
646,392 |
$8,739,219.84 |
0.88% |
| HCA Healthcare, Inc. |
HCA |
40412C101 |
Health Care Providers |
22,449 |
$8,348,109.63 |
0.84% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals and Biotechnology |
17,619 |
$8,326,210.83 |
0.84% |
| Tempus AI, Inc. (Class A) |
TEM |
88023B103 |
Pharmaceuticals and Biotechnology |
151,082 |
$7,094,810.72 |
0.71% |
| Illumina, Inc. |
ILMN |
452327109 |
Pharmaceuticals and Biotechnology |
24,889 |
$4,750,563.43 |
0.48% |
| DexCom, Inc. |
DXCM |
252131107 |
Medical Equipment and Services |
64,976 |
$4,641,235.68 |
0.47% |
| The Ensign Group, Inc. |
ENSG |
29358P101 |
Health Care Providers |
27,298 |
$4,616,364.78 |
0.47% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
Medical Equipment and Services |
14,903 |
$4,559,721.88 |
0.46% |
| IDEXX Laboratories, Inc. |
IDXX |
45168D104 |
Medical Equipment and Services |
8,313 |
$4,530,585.00 |
0.46% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals and Biotechnology |
12,084 |
$4,423,348.20 |
0.45% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals and Biotechnology |
76,477 |
$4,466,256.80 |
0.45% |
| Envista Holdings Corporation |
NVST |
29415F104 |
Medical Equipment and Services |
166,075 |
$4,389,362.25 |
0.44% |
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals and Biotechnology |
17,232 |
$4,405,016.16 |
0.44% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals and Biotechnology |
34,055 |
$4,340,990.85 |
0.44% |
| Revvity, Inc. |
RVTY |
714046109 |
Medical Equipment and Services |
39,331 |
$4,347,648.74 |
0.44% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
Medical Equipment and Services |
12,190 |
$4,369,017.90 |
0.44% |
| Stryker Corporation |
SYK |
863667101 |
Medical Equipment and Services |
13,898 |
$4,297,817.52 |
0.43% |
| The Cooper Companies, Inc. |
COO |
216648501 |
Medical Equipment and Services |
61,023 |
$4,302,121.50 |
0.43% |
| Danaher Corporation |
DHR |
235851102 |
Medical Equipment and Services |
22,974 |
$4,115,562.36 |
0.41% |
| US Dollar |
$USD |
|
Other |
2,230,655 |
$2,230,654.82 |
0.22% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|